BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2734333)

  • 1. Effect of nicotine pretreatment on striatal dopaminergic system in rats.
    Fung YK; Lau YS
    Pharmacol Biochem Behav; 1989 Jan; 32(1):221-6. PubMed ID: 2734333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats.
    Fung YK; Lau YS
    Eur J Pharmacol; 1988 Aug; 152(3):263-71. PubMed ID: 3220106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of nicotine on the striatal dopaminergic system in the rat.
    Fung YK; Lau YS
    J Pharm Pharmacol; 1986 Dec; 38(12):920-2. PubMed ID: 2880968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of nicotine on mesolimbic dopaminergic system in rats.
    Fung YK; Lau YS
    Pharmacol Biochem Behav; 1992 Jan; 41(1):57-63. PubMed ID: 1347177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
    Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
    J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal effects of maternal nicotine exposure on the striatal dopaminergic system in rats.
    Fung YK
    J Pharm Pharmacol; 1989 Aug; 41(8):576-8. PubMed ID: 2571708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems.
    Fung YK; Lau YS
    Pharmacol Biochem Behav; 1989 May; 33(1):1-6. PubMed ID: 2780768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.
    Jutkiewicz EM; Nicolazzo DM; Kim MN; Gnegy ME
    Psychopharmacology (Berl); 2008 Sep; 200(1):93-103. PubMed ID: 18566803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic nicotine pretreatment on (+)-amphetamine and nicotine-induced synthesis and release of [3H]dopamine from [3H]tyrosine in rat nucleus accumbens.
    Fung YK
    J Pharm Pharmacol; 1989 Jan; 41(1):66-8. PubMed ID: 2565971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic treatment with nicotine enhances the sensitivity of dopamine autoreceptors that modulate dopamine release from the rat striatum].
    Takaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):335-44. PubMed ID: 7584728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T; Katsura M; Kuriyama K
    Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Wiener HL; Lajtha A; Sershen H
    Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites.
    Howlett DR; Nahorski SR
    Brain Res; 1979 Jan; 161(1):173-8. PubMed ID: 758968
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects of chronic nicotine administration on dopaminergic receptor binding sites in rat nigrostriatal and mesolimbic regions.
    Fung YK; Lau YS
    Gen Pharmacol; 1991; 22(1):117-9. PubMed ID: 2050279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS; Runice C
    Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short post-weaning social isolation induces long-term changes in the dopaminergic system and increases susceptibility to psychostimulants in female rats.
    Lampert C; Arcego DM; de Sá Couto-Pereira N; Dos Santos Vieira A; Toniazzo AP; Krolow R; Garcia E; Vendite DA; Calcagnotto ME; Dalmaz C
    Int J Dev Neurosci; 2017 Oct; 61():21-30. PubMed ID: 28559209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C; Spahn SA; Ikegami H
    Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.